Company Encyclopedia
View More
name
Aveanna Healthcare
AVAH.US
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services.
384.02 B
AVAH.USMarket value -Rank by Market Cap -/-

Financial Score

22/11/2025 Update
C
Health Care ServicesIndustry
Industry Ranking30/80
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-104.04%E
    • Profit Margin3.29%C
    • Gross Margin32.61%C
  • Growth ScoreA
    • Revenue YoY15.48%B
    • Net Profit YoY214.61%A
    • Total Assets YoY10.11%B
    • Net Assets YoY106.40%A
  • Cash ScoreA
    • Cash Flow Margin3035.42%A
    • OCF YoY15.48%B
  • Operating ScoreA
    • Turnover1.33A
  • Debt ScoreE
    • Gearing Ratio99.45%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Aveanna Healthcare Updates Stockholders Agreement and Board

    Aveanna Healthcare Holdings amended its Stockholders Agreement on November 13, 2025, restricting certain executives from transferring common stock without pre-approval, while allowing other stockholders to transfer shares freely. Christopher Gordon resigned as a Class II director, and Sam Weil from Bain Capital was appointed to the board. The most recent analyst rating on AVAH stock is a Hold with a $10.00 price target. AVAH's financial performance shows strong revenue and EBITDA growth but is constrained by high leverage and negative equity.

    Tip Ranks·
    US
    AVAH
    +5.30%
    Tip Ranks·
    US
    AVAH
    +5.30%

    BMO Capital Issues Buy Rating for Aveanna Healthcare Holdings Amid Strategic Growth and Financial Performance

    BMO Capital has initiated a Buy rating for Aveanna Healthcare Holdings (AVAH), citing strong financial performance and strategic growth initiatives. The company's stock value has risen due to state reimbursement rate increases and effective cost management, reducing its leverage ratio. Aveanna's strategy to negotiate higher reimbursement rates allows for competitive caregiver wages, addressing supply-demand issues in home care. This approach is expected to boost patient volumes and long-term EBITDA growth. Barclays also maintains a Buy rating with a $9.00 price target.

    Tip Ranks·
    US
    AVAH
    +5.30%
    Tip Ranks·
    US
    AVAH
    +5.30%

    Aveanna Healthcare Holdings (AVAH) Gets a Hold from RBC Capital

    RBC Capital analyst Ben Hendrix has maintained a Hold rating on Aveanna Healthcare Holdings (AVAH) with a price target of $10.00. The stock closed at $8.95. Hendrix, a 4-star analyst, has an average return of 5.8% and a 53.54% success rate. The consensus on Aveanna is a Moderate Buy with an average price target of $10.36, indicating a 15.75% upside. UBS also holds a Hold rating with a $9.50 price target.

    Tip Ranks·
    US
    AVAH
    +5.30%
    Tip Ranks·
    US
    AVAH
    +5.30%

    Aveanna Healthcare Holdings (AVAH): Assessing Valuation Following Strong Q3 Results and Raised Guidance

    Aveanna Healthcare Holdings (AVAH) reported strong Q3 results, showcasing significant revenue and EBITDA growth, and returning to profitability. The company raised its full-year revenue guidance, leading to a year-to-date share price return of 94%. Analysts suggest the fair value is $9.61, indicating the stock is undervalued at its last close of $8.75. Aveanna trades at a P/E ratio of 24.2x, above the industry average, but below peers. Key risks include wage inflation and regulatory pressures on Medicare and Medicaid, which could impact future growth.

    Simplywall·
    US
    AVAH
    +5.30%
    Simplywall·
    US
    AVAH
    +5.30%

    Aveanna Healthcare (NASDAQ:AVAH) Issues Earnings Results

    Aveanna Healthcare (NASDAQ:AVAH) reported earnings of $0.15 EPS for the quarter, exceeding estimates of $0.07. Revenue reached $621.94 million, surpassing expectations of $578.57 million. The company has a negative return on equity of 103.46% and a net margin of 3.29%. Aveanna updated its FY 2025 guidance. Analysts have mixed ratings, with price targets ranging from $9.00 to $10.00. Recent insider sales totaled 32.6 million shares, and institutional investors have increased their stakes in the company.

    Market Beat·
    US
    AVAH
    +5.30%
    Market Beat·
    US
    AVAH
    +5.30%